Tech Company Financing Transactions

Chimerix Funding Round

Alta Partners, Asset Management Ventures and Canaan Partners participated in a $16 million Series E funding round for Chimerix. The round was announced by the company on 8/11/2009.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

2505 Meridian Pkwy. 100
Durham, NC 27713
USA

Phone

(919) 806-1074

Website

www.chimerix.com

Email Address

[email protected]

Overview

Incorporated in 2000, Chimerix is a biopharmaceutical company committed to the discovery, development, and commercialization of novel oral antiviral therapeutics that are designed to transform patient care in areas of high unmet medical need.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Michael Sherman

        

Chief Medical Officer

Garrett Nichols

        

Chief Scientific Officer

Randall Lanier

        

VP - Client Services

Odin Naderer

        

VP - General Counsel

Michael Alrutz

        

VP - Manufacturing

Roy Ware

        

Browse more venture capital transactions:

Prev: 8/11/2009: MyWebGrocer venture capital transaction
Next: 8/11/2009: iMemories venture capital transaction

Share this article

About Our VC Transactions Data

Our team works diligently to report on every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary